| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 5.07e-05 | 330 | 26 | 5 | GO:0040029 | |
| Domain | ARM-type_fold | 1.13e-02 | 339 | 26 | 3 | IPR016024 | |
| Domain | KRAB | 1.31e-02 | 358 | 26 | 3 | PS50805 | |
| Domain | KRAB | 1.31e-02 | 358 | 26 | 3 | PF01352 | |
| Domain | KRAB | 1.42e-02 | 369 | 26 | 3 | SM00349 | |
| Domain | KRAB | 1.43e-02 | 370 | 26 | 3 | IPR001909 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 33826602 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.95e-06 | 341 | 27 | 5 | 32971831 | |
| Pubmed | 1.44e-05 | 1084 | 27 | 7 | 11544199 | ||
| Pubmed | 1.52e-05 | 195 | 27 | 4 | 19454010 | ||
| Pubmed | 2.03e-05 | 210 | 27 | 4 | 16565220 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.37e-05 | 774 | 27 | 6 | 15302935 | |
| Pubmed | 3.27e-05 | 486 | 27 | 5 | 20936779 | ||
| Pubmed | 4.09e-05 | 86 | 27 | 3 | 37253089 | ||
| Pubmed | 6.32e-05 | 281 | 27 | 4 | 24163370 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 6.50e-05 | 283 | 27 | 4 | 30585729 | |
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 8.81e-05 | 18 | 27 | 2 | 23698369 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 9.59e-05 | 313 | 27 | 4 | 38270169 | |
| Pubmed | 1.09e-04 | 20 | 27 | 2 | 15504738 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.12e-04 | 1024 | 27 | 6 | 24711643 | |
| Pubmed | 1.15e-04 | 634 | 27 | 5 | 34591612 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.20e-04 | 332 | 27 | 4 | 32786267 | |
| Pubmed | 1.32e-04 | 653 | 27 | 5 | 22586326 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.43e-04 | 665 | 27 | 5 | 30457570 | |
| Pubmed | 2.17e-04 | 28 | 27 | 2 | 35474067 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 2.26e-04 | 153 | 27 | 3 | 26365490 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.32e-04 | 394 | 27 | 4 | 27248496 | |
| Pubmed | 2.66e-04 | 31 | 27 | 2 | 26678539 | ||
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 2.82e-04 | 165 | 27 | 3 | 16107646 | |
| Pubmed | 2.95e-04 | 777 | 27 | 5 | 35844135 | ||
| Pubmed | Gene expression profiling in the developing secondary palate in the absence of Tbx1 function. | 3.21e-04 | 34 | 27 | 2 | 29866044 | |
| Pubmed | 3.58e-04 | 179 | 27 | 3 | 19074885 | ||
| Pubmed | 3.65e-04 | 814 | 27 | 5 | 23251661 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.96e-04 | 1294 | 27 | 6 | 30804502 | |
| Pubmed | 4.06e-04 | 457 | 27 | 4 | 22190034 | ||
| Pubmed | 4.48e-04 | 469 | 27 | 4 | 27634302 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 4.52e-04 | 853 | 27 | 5 | 28718761 | |
| Pubmed | 4.59e-04 | 472 | 27 | 4 | 38943005 | ||
| Pubmed | 4.88e-04 | 199 | 27 | 3 | 36688959 | ||
| Pubmed | 5.00e-04 | 483 | 27 | 4 | 36912080 | ||
| Pubmed | 5.83e-04 | 503 | 27 | 4 | 16964243 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.86e-04 | 212 | 27 | 3 | 33853758 | |
| Pubmed | 6.36e-04 | 218 | 27 | 3 | 19460752 | ||
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 6.61e-04 | 221 | 27 | 3 | 29991511 | |
| Pubmed | 6.70e-04 | 1429 | 27 | 6 | 35140242 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.82e-04 | 934 | 27 | 5 | 33916271 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 7.51e-04 | 954 | 27 | 5 | 36373674 | |
| Interaction | H2BC4 interactions | 2.16e-05 | 259 | 27 | 5 | int:H2BC4 | |
| Interaction | H2BC21 interactions | 2.76e-05 | 696 | 27 | 7 | int:H2BC21 | |
| Interaction | SRSF4 interactions | 4.36e-05 | 300 | 27 | 5 | int:SRSF4 | |
| Interaction | AMOT interactions | 5.26e-05 | 312 | 27 | 5 | int:AMOT | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.80e-02 | 718 | 17 | 3 | 28 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 5.17e-07 | 300 | 27 | 6 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.94e-05 | 856 | 27 | 7 | M4500 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.34e-05 | 180 | 27 | 4 | M8239 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_UP | 3.95e-05 | 188 | 27 | 4 | MM1071 | |
| Coexpression | GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP | 4.56e-05 | 195 | 27 | 4 | M7125 | |
| Coexpression | GSE42724_NAIVE_VS_MEMORY_BCELL_DN | 5.03e-05 | 200 | 27 | 4 | M9793 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 8.22e-05 | 227 | 27 | 4 | M18441 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 9.55e-05 | 236 | 27 | 4 | M130 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.02e-04 | 466 | 27 | 5 | M13522 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | 1.83e-04 | 845 | 27 | 6 | M18090 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 1.08e-05 | 1257 | 26 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 3.56e-05 | 1459 | 26 | 9 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-06 | 192 | 27 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.33e-06 | 193 | 27 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.78e-06 | 197 | 27 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-06 | 199 | 27 | 4 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-06 | 199 | 27 | 4 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.14e-06 | 200 | 27 | 4 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.33e-05 | 135 | 27 | 3 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | 3'_v3-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Lung / Manually curated celltypes from each tissue | 1.28e-04 | 163 | 27 | 3 | 47300dec94dc66e965bf71fafff0a9fd24fae968 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 172 | 27 | 3 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.61e-04 | 176 | 27 | 3 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 176 | 27 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-04 | 177 | 27 | 3 | a235ff4f37a7622216526191efc4832fb8ed6957 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-04 | 177 | 27 | 3 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-04 | 179 | 27 | 3 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.80e-04 | 183 | 27 | 3 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 183 | 27 | 3 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.86e-04 | 185 | 27 | 3 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 185 | 27 | 3 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 1.86e-04 | 185 | 27 | 3 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 191 | 27 | 3 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 193 | 27 | 3 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | severe-Myeloid-Neutrophils_3|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.11e-04 | 193 | 27 | 3 | f4d43dfbf4115dd0f843ea5cf08049220342a047 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-04 | 194 | 27 | 3 | d840c1949c328779426c9172e02da09e968f0567 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 2.17e-04 | 195 | 27 | 3 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-04 | 195 | 27 | 3 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.20e-04 | 196 | 27 | 3 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 197 | 27 | 3 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 2.27e-04 | 198 | 27 | 3 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.31e-04 | 199 | 27 | 3 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | critical-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.31e-04 | 199 | 27 | 3 | 9284956d852e434a91be892e88e06a7c71f8c583 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.31e-04 | 199 | 27 | 3 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.31e-04 | 199 | 27 | 3 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-04 | 200 | 27 | 3 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 2.34e-04 | 200 | 27 | 3 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory-diff|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.34e-04 | 51 | 27 | 2 | a6f623dba72ce85683e692a68095926e4e71b765 | |
| ToppCell | control-Epithelial-Secretory-diff|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.94e-04 | 69 | 27 | 2 | 2c1eb6b358c323b4b6a642f473068681987a9e91 | |
| ToppCell | control-Epithelial-Secretory-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.88e-04 | 73 | 27 | 2 | dded04580ac197d3471a8ed43e1e61c56ee09f78 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.20e-03 | 85 | 27 | 2 | 2429bacccd103e5b2414264b4aff3103ed9d7cec | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2.Synpr-Nnat_(Neuron.Gad1Gad2.Synpr-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.20e-03 | 85 | 27 | 2 | 642755ed2b562dd5e599a04a2b9730e8d29aefe8 | |
| ToppCell | PSB-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-03 | 91 | 27 | 2 | 9c61b9f3e9e4f0c9cb242e313d642c2b75705c88 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.89e-03 | 107 | 27 | 2 | d694e72244d0b79be7e47c393c06aa55d504aba8 | |
| ToppCell | moderate-Epithelial-Secretory-diff|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.96e-03 | 109 | 27 | 2 | f2a07c6a71f6e4587bdc7b85f915bd287028cf17 | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 2.11e-03 | 113 | 27 | 2 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-03 | 116 | 27 | 2 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-03 | 118 | 27 | 2 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-03 | 118 | 27 | 2 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.45e-03 | 122 | 27 | 2 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.57e-03 | 125 | 27 | 2 | b82ce58b6262b0739c788395766e5fc77d2744f2 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-03 | 129 | 27 | 2 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-03 | 130 | 27 | 2 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.86e-03 | 132 | 27 | 2 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-03 | 134 | 27 | 2 | 0b1bb6fee8a2d8c27bca6d9cac6b47e85073dbf7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.94e-03 | 134 | 27 | 2 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-03 | 138 | 27 | 2 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-03 | 139 | 27 | 2 | 6396434c1cb209193ccdf15581ec2adacf941d85 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-03 | 143 | 27 | 2 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.53e-03 | 147 | 27 | 2 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.57e-03 | 148 | 27 | 2 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 3.62e-03 | 149 | 27 | 2 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-03 | 149 | 27 | 2 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-03 | 150 | 27 | 2 | c3ad5fa41eb636a5d691c0268c0f1c32cd0de658 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.67e-03 | 150 | 27 | 2 | 78b8029e71d26f336a46274c8afef3435bf536b9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-03 | 151 | 27 | 2 | 14c6f5d7441083861077b7362e6867d820aef864 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.72e-03 | 151 | 27 | 2 | 60aced0c1cc6b509b73308d03d58a3c44d712ef4 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.72e-03 | 151 | 27 | 2 | 71841d2001200d1595c85c2b007ee20791a72927 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-03 | 151 | 27 | 2 | c06a54afe918b14f885d6a85fbcf81e80f33afae | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.77e-03 | 152 | 27 | 2 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-03 | 154 | 27 | 2 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.86e-03 | 154 | 27 | 2 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-03 | 156 | 27 | 2 | e6798d2b9c2c1fc6525c24f596f25aa85a375651 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-03 | 156 | 27 | 2 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.96e-03 | 156 | 27 | 2 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-03 | 156 | 27 | 2 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.96e-03 | 156 | 27 | 2 | 8349604bd801e20d33770f7d8243598c3756302b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.01e-03 | 157 | 27 | 2 | 5fb41af247465aa29aa7b8edd26e3d3794766f80 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.01e-03 | 157 | 27 | 2 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-03 | 158 | 27 | 2 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-03 | 158 | 27 | 2 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.11e-03 | 159 | 27 | 2 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.16e-03 | 160 | 27 | 2 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.21e-03 | 161 | 27 | 2 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.21e-03 | 161 | 27 | 2 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.21e-03 | 161 | 27 | 2 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.21e-03 | 161 | 27 | 2 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-03 | 161 | 27 | 2 | b9a63fc9becc44d305fc7c221283bf59ec06b10f | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.26e-03 | 162 | 27 | 2 | 7f425a3983325a5a3ea33f812b15aa010cc55de0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.31e-03 | 163 | 27 | 2 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-03 | 163 | 27 | 2 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-03 | 163 | 27 | 2 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-03 | 163 | 27 | 2 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.15e-05 | 50 | 17 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.15e-05 | 50 | 17 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | perflubron | 3.25e-07 | 12 | 27 | 3 | CID000009873 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 5.88e-05 | 181 | 27 | 4 | 1791_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 6.95e-05 | 189 | 27 | 4 | 2041_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.24e-05 | 191 | 27 | 4 | 6236_UP | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 7.39e-05 | 192 | 27 | 4 | 1599_DN | |
| Drug | diisopropylcarbodiimide | 7.40e-05 | 11 | 27 | 2 | CID000012734 | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 8.00e-05 | 196 | 27 | 4 | 2314_DN | |
| Drug | Quinic acid [86-68-0]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 3540_DN | |
| Drug | Ketoprofen [22071-15-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 4286_UP | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.32e-05 | 198 | 27 | 4 | 3788_UP | |
| Drug | Furazolidone [67-45-8]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 8.49e-05 | 199 | 27 | 4 | 3358_UP | |
| Drug | Chlorpheniramine | 1.61e-04 | 16 | 27 | 2 | ctd:D002744 | |
| Drug | etanidazole | 2.29e-04 | 19 | 27 | 2 | CID000003276 | |
| Drug | dichloromethyl | 2.54e-04 | 20 | 27 | 2 | CID000123193 | |
| Drug | tren | 2.80e-04 | 21 | 27 | 2 | CID000077731 | |
| Drug | Vincristine | 3.54e-04 | 1182 | 27 | 7 | ctd:D014750 | |
| Drug | Gd-DTPA | 3.68e-04 | 24 | 27 | 2 | CID000055466 | |
| Drug | Demecolcine | 4.77e-04 | 878 | 27 | 6 | ctd:D003703 | |
| Drug | Vitamin K 3 | 4.95e-04 | 1249 | 27 | 7 | ctd:D024483 | |
| Drug | 1,2-dioxane | 5.39e-04 | 29 | 27 | 2 | CID000138570 | |
| Drug | hexafluorophosphate | 7.42e-04 | 34 | 27 | 2 | CID000009886 | |
| Drug | 3'-deoxyguanosine | 7.42e-04 | 34 | 27 | 2 | CID000165138 | |
| Drug | Chloroprene | 7.81e-04 | 1348 | 27 | 7 | ctd:D002737 | |
| Drug | Methamphetamine | 9.82e-04 | 1401 | 27 | 7 | ctd:D008694 | |
| Drug | Clorgyline | 1.01e-03 | 168 | 27 | 3 | ctd:D003010 | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A | 1.12e-03 | 174 | 27 | 3 | 2452_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.18e-03 | 177 | 27 | 3 | 985_DN | |
| Disease | total lipids in VLDL measurement | 2.01e-05 | 60 | 26 | 3 | EFO_0022314 | |
| Disease | triglycerides in medium LDL measurement | 2.22e-05 | 62 | 26 | 3 | EFO_0022322 | |
| Disease | cholesterol in very large VLDL measurement | 2.56e-05 | 65 | 26 | 3 | EFO_0022230 | |
| Disease | cholesterol in large VLDL measurement | 2.56e-05 | 65 | 26 | 3 | EFO_0021902 | |
| Disease | familial hyperlipidemia | 1.10e-04 | 106 | 26 | 3 | MONDO_0001336 | |
| Disease | amyloid-beta measurement | 2.50e-04 | 355 | 26 | 4 | EFO_0005194 | |
| Disease | Malignant neoplasm of breast | 2.82e-04 | 1074 | 26 | 6 | C0006142 | |
| Disease | Burkitt Lymphoma | 4.62e-04 | 36 | 26 | 2 | C0006413 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 4.88e-04 | 37 | 26 | 2 | EFO_0022252 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 5.32e-04 | 181 | 26 | 3 | DOID:684 (is_implicated_in) | |
| Disease | lip morphology measurement | 6.03e-04 | 189 | 26 | 3 | EFO_0007845 | |
| Disease | triglycerides in large LDL measurement | 6.59e-04 | 43 | 26 | 2 | EFO_0022319 | |
| Disease | Neuroblastoma | 7.88e-04 | 47 | 26 | 2 | C0027819 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 8.76e-04 | 215 | 26 | 3 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 9.37e-04 | 220 | 26 | 3 | EFO_0004529, EFO_0008317 | |
| Disease | Liver carcinoma | 9.54e-04 | 507 | 26 | 4 | C2239176 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 9.86e-04 | 224 | 26 | 3 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 9.86e-04 | 224 | 26 | 3 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 9.99e-04 | 225 | 26 | 3 | EFO_0008317, EFO_0010351 | |
| Disease | cholesterol in small VLDL measurement | 1.00e-03 | 53 | 26 | 2 | EFO_0022228 | |
| Disease | phospholipids:total lipids ratio | 1.03e-03 | 227 | 26 | 3 | EFO_0020946 | |
| Disease | total lipids in medium VLDL | 1.04e-03 | 54 | 26 | 2 | EFO_0022153 | |
| Disease | plasminogen activator inhibitor 1 measurement | 1.04e-03 | 54 | 26 | 2 | EFO_0004792 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.05e-03 | 229 | 26 | 3 | EFO_0004639, EFO_0008317 | |
| Disease | triglycerides in medium VLDL measurement | 1.08e-03 | 55 | 26 | 2 | EFO_0022155 | |
| Disease | triglycerides in LDL measurement | 1.12e-03 | 56 | 26 | 2 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 1.12e-03 | 56 | 26 | 2 | EFO_0022325 | |
| Disease | triglycerides in large VLDL measurement | 1.12e-03 | 56 | 26 | 2 | EFO_0022178 | |
| Disease | triglycerides in IDL measurement | 1.20e-03 | 58 | 26 | 2 | EFO_0022149 | |
| Disease | pre-eclampsia (is_marker_for) | 1.20e-03 | 58 | 26 | 2 | DOID:10591 (is_marker_for) | |
| Disease | triglycerides in VLDL measurement | 1.24e-03 | 59 | 26 | 2 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 1.24e-03 | 59 | 26 | 2 | EFO_0022301 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.28e-03 | 60 | 26 | 2 | EFO_0022330 | |
| Disease | free cholesterol in very large VLDL measurement | 1.32e-03 | 61 | 26 | 2 | EFO_0022274 | |
| Disease | triglycerides in small VLDL measurement | 1.32e-03 | 61 | 26 | 2 | EFO_0022145 | |
| Disease | free cholesterol in VLDL measurement | 1.32e-03 | 61 | 26 | 2 | EFO_0022276 | |
| Disease | phospholipids in large VLDL measurement | 1.37e-03 | 62 | 26 | 2 | EFO_0022169 | |
| Disease | phospholipids in very large VLDL measurement | 1.37e-03 | 62 | 26 | 2 | EFO_0022299 | |
| Disease | total lipids in very large VLDL measurement | 1.37e-03 | 62 | 26 | 2 | EFO_0022313 | |
| Disease | cholesteryl ester measurement | 1.46e-03 | 257 | 26 | 3 | EFO_0010351 | |
| Disease | triglycerides in small LDL measurement | 1.50e-03 | 65 | 26 | 2 | EFO_0022323 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.51e-03 | 260 | 26 | 3 | EFO_0008317 | |
| Disease | total lipids in small VLDL | 1.59e-03 | 67 | 26 | 2 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 1.59e-03 | 67 | 26 | 2 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.64e-03 | 68 | 26 | 2 | EFO_0022327 | |
| Disease | triglycerides in very small VLDL measurement | 1.64e-03 | 68 | 26 | 2 | EFO_0022144 | |
| Disease | free cholesterol in large VLDL measurement | 1.64e-03 | 68 | 26 | 2 | EFO_0022265 | |
| Disease | cancer (implicated_via_orthology) | 1.65e-03 | 268 | 26 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small HDL percentage | 1.84e-03 | 72 | 26 | 2 | EFO_0022336 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.09e-03 | 291 | 26 | 3 | EFO_0008317, EFO_0020946 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.15e-03 | 78 | 26 | 2 | EFO_0022187 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKKSSKKANTSSSSS | 26 | Q9Y2F9 | |
| TESKSKKSSSSTTTN | 991 | O14497 | |
| QSASSTLQKHKSSSS | 841 | O95819 | |
| TSTTSSRKSKQHQSS | 796 | Q9H2X6 | |
| HAQDTKSSGQSTSKK | 676 | Q9BXT6 | |
| HGSSSGTKSSKKKNQ | 101 | Q9H2S1 | |
| AQSVTTKKVSSSTNK | 5726 | Q5CZC0 | |
| SVSKTSTSHVSVSKT | 3496 | P98088 | |
| TPKTDNTKSSSSSQK | 1066 | Q7Z6E9 | |
| SHQGKKSGTSSKLSV | 1206 | Q5VT06 | |
| SSTQSKSNKTSQKHV | 161 | Q5FWF5 | |
| TKTSSSQLNKSQSHM | 96 | A6NGG8 | |
| KGKSSSAQQKTVSST | 2461 | P11717 | |
| KSTNTSQTGLVGTKH | 396 | Q96R06 | |
| KTSPTTQSKHNTTSA | 2241 | Q5UIP0 | |
| ITNTKKGKSHKSQSS | 1351 | Q6Q759 | |
| KEIKSQSSSSSSSHK | 831 | P51825 | |
| TNGKKTSPQVKSSTH | 131 | Q6ZUT1 | |
| RTQSKTSTSTQKHSG | 91 | A6NM28 | |
| KSSSSGKKTAKTNTN | 191 | P13726 | |
| VKKTAAKSQSSTSTT | 1416 | P11388 | |
| GVSSLGSKSSHKTTK | 81 | O60765 | |
| GSKSSHKTTKSTQTQ | 86 | O60765 | |
| SQDSSSGKKVSHKST | 201 | Q6XPR3 | |
| SGQATTQSKSSTKKS | 3356 | Q5T4S7 | |
| NKSTGKSASSVKSVV | 806 | Q14966 | |
| GKSFSQSSTLTTHKI | 496 | O75437 | |
| SKQSTASKQTTASKQ | 181 | P52179 | |
| ASKQTTASKQSTASK | 186 | P52179 |